GNH USA

Europe — EMA

Minirin (Desmopressin)

GNH USA supplies Minirin (Desmopressin), a antidiuretic hormone for central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease.

Request sourcing

1
Pack/s

What is Desmopressin?

Desmopressin, the active ingredient in Minirin, is a antidiuretic (vasopressin analog) presented as a sublingual tablet for sublingual use. It treats central diabetes insipidus, nocturnal enuresis, and is used as adjunct therapy in hemophilia A and von Willebrand disease.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Desmopressin used for?

Desmopressin is a synthetic vasopressin analog that acts on the antidiuretic pathway to reduce urine output and increase coagulation factor levels.

- Central diabetes insipidus: reduces excessive urine production by enhancing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Hemophilia A (as adjunct therapy): raises plasma factor VIII levels to support clot formation. - von Willebrand disease (as adjunct therapy): increases von Willebrand factor to improve platelet adhesion.

What are the side effects of Desmopressin?

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache - Nausea - Mild throat irritation - Abdominal discomfort

Serious or Rare Side Effects: - Severe hyponatraemia - Seizures - Allergic reactions such as rash or angioedema - Water intoxication leading to cerebral oedema

What precautions apply to Desmopressin?

Before prescribing Minirin, clinicians should consider several safety aspects.

- Renal function: assess in patients with impaired kidney function. - Electrolytes: monitor serum sodium regularly, especially in the elderly. - Fluid intake: limit excessive water consumption to avoid hyponatraemia. - Concomitant drugs: avoid use with other antidiuretic agents. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Desmopressin interact with?

Desmopressin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Co‑administration with other vasopressin analogues or ADH agonists: risk of profound hyponatraemia. - Concurrent use of carbamazepine: may diminish antidiuretic effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may potentiate antidiuretic activity, monitor sodium levels. - Thiazide diuretics: increase risk of hyponatraemia. - Selective serotonin reuptake inhibitors (SSRIs): additive hyponatraemia risk.

Frequently asked questions

What conditions is Minirin used to treat?+
Minirin (desmopressin) is prescribed for central diabetes insipidus to reduce excessive urine output, for nocturnal enuresis to lessen nighttime bedwetting, and as an adjunct in hemophilia A and von Willebrand disease to raise clotting factor levels.
How does desmopressin work in the body?+
Desmopressin acts as a selective V2‑receptor agonist. In the kidneys it promotes aquaporin‑2 channel insertion, increasing water reabsorption. In endothelial cells it stimulates release of factor VIII and von Willebrand factor, enhancing haemostasis.
What determines the dose of Minirin?+
The dose of Minirin is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function and response to therapy. No universal dosing regimen is provided in product literature.
Is Minirin safe during pregnancy or breastfeeding?+
Safety data for desmopressin in pregnancy and lactation are limited. It is classified as pregnancy category unknown, so it should only be used when the potential benefit justifies any possible risk to the fetus or infant.
How do I order Minirin from GNH USA?+
To order Minirin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Minirin compare with other antidiuretic agents?+
Compared with natural vasopressin, desmopressin has a longer half‑life and greater selectivity for V2 receptors, offering prolonged antidiuretic effect with fewer vasoconstrictive (V1) actions. It is also more convenient as a sublingual tablet versus injectable vasopressin.
What are the recommended storage conditions for Minirin?+
Minirin tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight to maintain stability and potency.
How is Minirin administered?+
The sublingual tablet is placed under the tongue and allowed to dissolve completely without drinking water. Patients should remain upright for several minutes to ensure optimal absorption.
What are the most serious risks to watch for while using Minirin?+
The most critical risks include severe hyponatraemia, which can lead to seizures or cerebral oedema, and water intoxication. Prompt monitoring of serum sodium and fluid intake is essential to mitigate these hazards.
Who should not use Minirin?+
Minirin is contraindicated in patients with existing hyponatraemia, uncontrolled fluid intake, severe renal impairment, or known hypersensitivity to desmopressin. Caution is also advised for individuals on interacting medications that affect sodium balance.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Desmopressin
Route
Sublingual Use
Manufacturer
Ferring Gmbh
Origin
EU

Related products